What's New

All the latest immuno-oncology content and news in one place.

Application Note: Highly Specific and Sensitive Methods for In-Tissue and Soluble PD-L1 Detection


Immune checkpoint blockade of the PD-1/PD-L1 pathway has provided the blueprint for cancer immunotherapy. But inconsistencies surrounding the current methods of PD-L1 detection, patient stratification, and consequently, therapeutic efficacy remain. Therefore, alternative methods of detection that are reliable, quantitative, and objective are necessary. In this application note, get acquainted with novel approaches sure to advance your in-tissue and soluble PD-L1 detection workflow.

Download App Note

Guide: Tools for Targeting Immuno-Oncology


We are committed to advancing immune-oncology and unlocking its full clinical potential. Download the new guide to get a comprehensive look at our diverse portfolio of solutions and capabilities.

Download Guide